Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management

May 9, 2024 UCBN News, Syndication Comments Off on Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management

LOUISVILLE, Colo.–(BUSINESS WIRE)—- $BDSX #patientsfirst–Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for the first quarter ended March 31, 2024, and provided a corporate update. “I am very pleased to announce yet another quarter of greater than 50% revenue and volume growth and 14 percentage point improvement in gross margins,” said Scott Hutton, CEO of Biodesix. “This is a year of execution with three main g
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Related Articles

No Picture
News

New Research on Climate Change, Gut Health, and Socioeconomic Status’ Impact on Stroke and Aneurysm Care to Be Presented at Society of NeuroInterventional Surgery’s 21st Annual Meeting

July 18, 2024 UCBN News, Syndication Comments Off on New Research on Climate Change, Gut Health, and Socioeconomic Status’ Impact on Stroke and Aneurysm Care to Be Presented at Society of NeuroInterventional Surgery’s 21st Annual Meeting

COLORADO SPRINGS, Colo., July 18, 2024 /PRNewswire/ — Neurointerventional surgeons from across the globe will gather at the Society of NeuroInterventional Surgery’s (SNIS) 21st Annual Meeting from July 22 through July 25 in Colorado Springs, […]